We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cannara Biotech Inc | TSXV:LOVE | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.06 | 7.50% | 0.86 | 0.84 | 0.87 | 0.86 | 0.80 | 0.80 | 49,500 | 21:00:00 |
Access to Documents
The Proxy-Related Materials are available under the Company’s profile on SEDAR+ at www.sedarplus.ca or on Cannara’s website at www.cannara.ca/investors.
Date and Time of the Meeting
The Meeting will be held a virtual-only format, which will be conducted via live audio webcast and teleconference accessible via the following link:
https://cannarabiotechquebecinc.my.webex.com/cannarabiotechquebecinc.my/j.php?MTID=m70400f296058ebb021572737a5824d6a
To join the meeting via teleconference, please dial 1-438-797-4001 (Canada) or 1-650-479-3208 (US) and use meeting code 2636 952 9781 and passcode LOVE2025 (56832025 when dialing from a phone or video system). Shareholders accessing the Meeting via teleconference will not be able to vote or speak at the Meeting. To vote or speak at the Meeting, shareholders will need to join the webcast and utilize the chat function during the Meeting. A moderator will be present to allow shareholders to vote or speak at the Meeting at the appropriate time.
Meeting Matters
In addition to receiving the Corporation’s consolidated financial statements for the fiscal year ended August 31, 2024, and the related auditor’s report, shareholders will be invited to vote on the following items at the meeting:
CSA Coordinated Blanket Order 51-913
Recognizing that Postal Strike may impact a reporting issuer’s ability to deliver proxy-related materials to all shareholders, the Canadian Securities Administrators (CSA) published on December 4, 2024, Coordinated Blanket Order 51-931 Temporary Exemption from requirements in National Instrument 51-102 Continuous Disclosure Requirements and National Instrument 54-101 Communication with Beneficial Owners of Securities of a Reporting Issuer to send certain proxy-related materials during a postal strike (“Blanket Order 51-931”), providing temporary relief from the requirement to deliver proxy-related materials for annual meetings.
The conditions in Blanket Order 51-931 include a requirement that each of the matters at the Meeting would be considered an “annual matter”. Cannara confirms that it has complied with all conditions of this exemption.Assistance
Shareholders of the Company are encouraged to access the Proxy-Related Materials directly through the above-mentioned websites, and registered shareholders and non-objecting beneficial shareholders may contact the Company’s transfer agent, Computershare Investor Services Inc. by calling toll free, within North America - 1-866-962-0498 or direct, from outside of North America - (514) 982-8716 to request copies of the Proxy-Related Materials or 1-800-564-6253 or direct, from outside of North America - 514-982-7555 to request voting control numbers for voting online at www.investorvote.com. Objecting beneficial shareholders should contact their broker to request their voting instruction forms, voting control numbers and instructions for voting.
In the event that the Postal Strike ends prior to the Meeting, the Company will mail the Proxy-Related Materials in the normal course, but there can be no assurance that the Proxy-Related Materials will be received by the shareholders prior to the Meeting.
ABOUT CANNARA
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.
CONTACT
Nicholas Sosiak, CPA, CAChief Financial Officernick@cannara.ca | Zohar Krivorot President & Chief Executive Officer zohar@cannara.ca |
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
1 Year Cannara Biotech Chart |
1 Month Cannara Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions